The potential global health impact and cost-effectiveness of next-generation influenza vaccines: A modelling analysis
This study highlights the considerable potential health and economic benefits of NGIVs, but also the variation in cost-effectiveness between high-income and low- and middle-income countries. This work provides a framework for long-term global cost-effectiveness evaluations, and the findings can inform a pathway to developing NGIVs and rolling them out globally.
Authors
- Naomi R. Waterlow (ORCID: https://orcid.org/0000-0002-9210-9657)
- Lucy Goodfellow (ORCID: https://orcid.org/0009-0004-0434-5863)
- Simon R. Procter (ORCID: https://orcid.org/0000-0002-0380-1503)
- Mihály Koltai (ORCID: https://orcid.org/0000-0002-7341-5114)
- João A. N. Filipe (ORCID: https://orcid.org/0000-0002-2353-7981)
- Edwin van Leeuwen (ORCID: https://orcid.org/0000-0002-2383-5305)
- Mark Jit (ORCID: https://orcid.org/0000-0001-6658-8255)
- Rosalind M. Eggo (ORCID: https://orcid.org/0000-0002-0362-6717)
- Carlos King Ho Wong (ORCID: https://orcid.org/0000-0002-6895-6071)
Institutions
- London School of Hygiene & Tropical Medicine (GB)
- Health Protection Agency (MV)
- Laboratory of Data Discovery for Health (HK)
Publication Details
- Journal
- PLoS Medicine
- Published
- 2025-06-30
- DOI
- https://doi.org/10.1371/journal.pmed.1004655
- Citations
- 6
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 8.13
Funders
- World Health Organization
- Wellcome Trust
- National Institute for Health Research Health Protection Research Unit
- Innovation and Technology Commission - Hong Kong
- Centers for Disease Control and Prevention